✦ LIBER ✦

Consolidative Renal Cell Carcinoma Metastatectomy for Partial Response After Multitargeted Tyrosine Kinase Inhibitor Therapy

✍ Scribed by Mischel G. Neill; Alice C. Wei; Michael A.S. Jewett

Book ID: 116947458
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 246 KB
Volume: 70
Category: Article
ISSN: 0090-4295
DOI: 10.1016/j.urology.2007.03.044

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pazopanib, a potent orally administered

Pazopanib, a potent orally administered small-molecule multitargeted tyrosine kinase inhibitor for renal cell carcinoma

✍ Sonpavde, Guru; Hutson, Thomas E; Sternberg, Cora N 📂 Article 📅 2008 🏛 Informa plc 🌐 English ⚖ 882 KB

Two cases of gastrointestinal perforatio

Two cases of gastrointestinal perforation after radiotherapy in patients receiving tyrosine kinase inhibitor for advanced renal cell carcinoma

✍ Takaaki Inoue, Hidefumi Kinoshita, Yoshihiro Komai, Takashi Kawabata, Gen Kawa, 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 278 KB

MP57-14 CHANGE IN PLATELET COUNT AS A PR

MP57-14 CHANGE IN PLATELET COUNT AS A PROGNOSTIC INDICATOR FOR RESPONSE TO NEOADJUVANT TYROSINE KINASE INHIBITOR THERAPY IN METASTATIC RENAL CELL CARCINOMA

✍ Lee, Hak; Patel, Nishant; Kopp, Ryan; Liss, Michael; Mehrazin, Reza; Jabaji, Ram 📂 Article 📅 2014 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 213 KB

Tyrosine Kinase Inhibitors Compared with

Tyrosine Kinase Inhibitors Compared with Cytokine Therapy for Metastatic Renal Cell Carcinoma: Overview of Recent Clinical Trials Differentiating Clinical Response and Adverse Effects

✍ Robert Dreicer 📂 Article 📅 2006 🏛 CIG Media Group, LP. 🌐 English ⚖ 151 KB

An international expanded-access program

An international expanded-access programme of everolimus: Addressing safety and efficacy in patients with metastatic renal cell carcinoma who progress after initial vascular endothelial growth factor receptor-tyrosine kinase inhibitor therapy

✍ Viktor Grünwald; Pierre I. Karakiewicz; Sevil E. Bavbek; Kurt Miller; Jean-Pasca 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 257 KB

Everolimus in Metastatic Renal Cell Carc

Everolimus in Metastatic Renal Cell Carcinoma after Failure of Initial Vascular Endothelial Growth Factor Receptor-Tyrosine Kinase Inhibitor (VEGFr-TKI) Therapy: Results of an Interim Analysis of a Non-Interventional Study

✍ Bergmann, Lothar; Goebell, Peter J.; Kube, Ulrich; Kindler, Manfred; Herrmann, E 📂 Article 📅 2013 🏛 S. Karger AG 🌐 English ⚖ 431 KB